We previously reported that plasma TRAP5b levels are increased in patients with GD, associated with osteopenia and osteoporosis, and positively correlated with GD clinical biomarkers CCL18, Lyso-Gb-1, and Chito [19]. This evidence concerns the gene CCL18 and Osteopenia.